(Q25256772)

9

object named as

Aldina Barral

0 references

Cláudia Brodskyn

6

object named as

Cláudia Brodskyn

0 references

Johan Van Weyenbergh

5

object named as

Johan van Weyenbergh

0 references

author name string

Arlene Caldas

1

0 references

Cecília Favali

2

0 references

Dorlene Aquino

3

0 references

Vera Vinhas

4

0 references

Jackson Costa

https://scigraph.springernature.com/pub.10.1186/1471-2334-5-113

7

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

BMC Infectious Diseases

0 references

volume

5

0 references

issue

1

0 references

page(s)

113

0 references

exact match

0 references

cites work

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Class and subclass selection in parasite-specific antibody responses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Antagonizing the differentiation and functions of human T helper type 2 cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Transforming growth factor-beta in human cutaneous leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Interleukin 6 during active visceral leishmaniasis and after treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Serum interferon activity of patients with leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

An analysis of T cell responsiveness in Indian kala-azar.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Cytokine profile and pathology in human leishmaniasis.

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Antileishmanial antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody responses occur in resistant subjects and are not predictive of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Serum cytokine profile in the subclinical form of visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-5-113

Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1343567

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis

28 November 2018

1 reference

12 December 2020

IL-10 AND IL-12 ARE THE MAIN REGULATORY CYTOKINES IN VISCERAL LEISHMANIASIS

1 reference

12 December 2020

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

1 reference

12 December 2020

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

12 December 2020

Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis

1 reference

12 December 2020

Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis

1 reference

12 December 2020

Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis

1 reference

12 December 2020

Presence of Circulating Levels of Interferon- g , Interleukin-10 and Tumor Necrosis Factor- a in Patients with Visceral Leishmaniasis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-5-113

1 reference

Dimensions Publication ID

1685125

1004365919

0 references

1685125

1 reference

1 reference

1 reference